Lantern Pharma Launches ZetaOmics™ — an Autonomous, Intelligent “Computational Biologist” That Brings Expert-Grade Bioinformatics, Biostatistics & Reasoning to Every Cancer
Lantern Pharma announced the launch of ZetaOmics, an autonomous AI module within its withZeta.ai platform designed to function as an expert-grade computational biologist. The system accesses over 615,000 curated cancer samples to perform rigorous multi-omic analysis and experimental design, initially available to select collaborators through an early access program.
Key figures
- Tool count
- 14
- Data sources
- 11
- Sample count
- 615000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.